ShopSpell

Prescribing Hemodialysis A Guide to Urea Modeling [Hardcover]

$295.99     $369.00    20% Off      (Free Shipping)
100 available
  • Category: Books (Gardening)
  • Author:  Depner, T.A.
  • Author:  Depner, T.A.
  • ISBN-10:  0792308336
  • ISBN-10:  0792308336
  • ISBN-13:  9780792308331
  • ISBN-13:  9780792308331
  • Publisher:  Springer
  • Publisher:  Springer
  • Binding:  Hardcover
  • Binding:  Hardcover
  • Pub Date:  01-Jan-1990
  • Pub Date:  01-Jan-1990
  • Pages:  291
  • Pages:  291
  • SKU:  0792308336-11-SPRI
  • SKU:  0792308336-11-SPRI
  • Item ID: 100861696
  • List Price: $369.00
  • Seller: ShopSpell
  • Ships in: 5 business days
  • Transit time: Up to 5 business days
  • Delivery by: Jul 12 to Jul 14
  • Notes: Brand New Book. Order Now.
What regulation shall we have for the operation? Shall a man transfuse he knows not what. to correct he knows not what. God knows how (l)? Dr. Henry Stubbs Royal College of Physicians circa 1670 If dialysis therapy were a new phannaceutical product being evaluated by the FDA now, it might not be approved for marketing. The recommended dose, its potential toxicity, the side effects of under-or over-dialysis as well as its efficacy have been the subject of very few studies. The high mortality rate associated with the treatment may raise a few eyebrows. That it is a life-saving modality of treatment is undoubtedly true for more than 100,000 patients in the United States and for more than a million patients world? wide. Because dialysis has extended the lives of many people by a variable period of time, most nephrologists have rested on their laurels and did not vigorously pursue studies to optimize these treatments. But facts have a way of intruding in all our lives and the facts are that the overall mortality rate of dialysis patients in the United States is rising and stands close to 25% per year and is closer to 33% per year for patients between the ages of 65 and 74 (2). These mortality figures are considerably higher for age-adjusted dialysis populations in Europe and particu? larly in Japan, and certainly for the age-adjusted nonnal population.What regulation shall we have for the operation? Shall a man transfuse he knows not what. to correct he knows not what. God knows how (l)? Dr. Henry Stubbs Royal College of Physicians circa 1670 If dialysis therapy were a new phannaceutical product being evaluated by the FDA now, it might not be approved for marketing. The recommended dose, its potential toxicity, the side effects of under-or over-dialysis as well as its efficacy have been the subject of very few studies. The high mortality rate associated with the treatment may raise a few eyebrows. That it is a life-saving modality of treatment is undoubtedly true for mlÓ¾
Add Review